The Latest Breaking News from ABBV

The pharma industry witnessed solid growth amid the pandemic. Moreover, with surging demand, rising investments in research and development, and increasing e-pharmacy channels, the industry is well-positioned for significant growth over the coming years. Therefore, investors could consider buying fundamentally sound pharma stocks Johnson & Johnson (JNJ), AbbVie (ABBV), and…

Despite recent signs of moderation in inflation, the better-than-expected January jobs data could force the Fed to raise interest rates even further. This is expected to keep the stock market highly volatile in the near term. Given a volatile market backdrop, investing in high-quality stocks AbbVie (ABBV), Cintas (CTAS), and…

The Fed will likely keep raising interest rates to bring inflation down to its desired level. This is expected to keep the stock market and the economy under pressure this year. Amid the uncertainty, investors looking for passive income could add fundamentally strong dividend-paying stocks AbbVie (ABBV), Valero Energy (VLO),…

Improving investors’ sentiments amid the cooling inflation and moderating interest rate increases helped the stock market to surge in recent weeks. Moreover, the IMF raised its world economy growth forecast. Given the rising optimism, AbbVie (ABBV), Vertex Pharmaceuticals (VRTX), Murphy (MUSA), MasterCraft Boat (MCFT), and PrimeEnergy Resources (PNRG) might be…

While the better-than-expected GDP growth in the last quarter and declining inflationary pressures are raising optimism, macro uncertainties remain. With interest rate hikes expected to continue, recession possibilities cannot be ruled out. Therefore, fundamentally sound dividend-paying stocks, AbbVie (ABBV), Gilead Sciences (GILD), and Sisecam Resources (SIRE), could be worth investing…

Even after inflation showed signs of cooling, fears of a recession continue to linger on investors. Despite having a muddled outlook of the market ahead, many experts believe there is still room for optimism. Given this backdrop, fundamentally sound high-quality stocks AbbVie (ABBV), Cisco Systems (CSCO), and Hugo Boss (BOSSY)…

Rising chronic diseases, an aging population, and surging healthcare spending should boost the pharmaceutical industry’s growth prospects. Moreover, the pharmaceutical industry usually holds up well during market downturns due to relatively inelastic demand for their products and services. Therefore, fundamentally sound pharma stocks Johnson & Johnson (JNJ), AbbVie (ABBV), and…

While inflation pressures seem to be cooling, the Fed is expected to continue with its rate hikes, raising the chances of a recession this year. Hence, high-dividend stocks AbbVie (ABBV), Gilead Sciences (GILD), and Marine Products (MPX) might be solid buys for steady income amid current uncertainties. Keep reading.

While the stock market and the economy have been subdued by progressive interest-rate increases, AbbVie Inc. (ABBV) has not only reported a robust third quarter but also demonstrated its confidence in its long-term prospects by raising its quarterly dividend. Read on….

Amid diminishing inflationary pressures, rate hikes are expected to slow down. However, the Fed might continue with the rate hikes. As a recession looks imminent, we think fundamentally sound dividend stocks AbbVie (ABBV), Marine Products (MPX), and Bassett Furniture Industries (BSET) might be ideal buy-and-hold options to ensure a steady…

Although inflation slowed further in December, concerns of a recession weigh heavy on investors’ sentiments as the Fed plans to continue raising interest rates this year. Amid this backdrop, investors could consider buying fundamentally strong stocks AbbVie (ABBV), The Coca-Cola Company (KO), and Centene Corporation (CNC) for the long-term. Read…